{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T16:30:53Z","timestamp":1773419453775,"version":"3.50.1"},"reference-count":39,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T00:00:00Z","timestamp":1762819200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003407","name":"Ministero dell\u2019Istruzione, dell\u2019Universit\u00e0 e della Ricerca","doi-asserted-by":"publisher","award":["CUP B53D23008390006"],"award-info":[{"award-number":["CUP B53D23008390006"]}],"id":[{"id":"10.13039\/501100003407","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003407","name":"Ministero dell\u2019Istruzione, dell\u2019Universit\u00e0 e della Ricerca","doi-asserted-by":"publisher","award":["PRJ-0863 PRIN2022"],"award-info":[{"award-number":["PRJ-0863 PRIN2022"]}],"id":[{"id":"10.13039\/501100003407","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003407","name":"Ministero dell\u2019Istruzione, dell\u2019Universit\u00e0 e della Ricerca","doi-asserted-by":"publisher","award":["PE_00000019"],"award-info":[{"award-number":["PE_00000019"]}],"id":[{"id":"10.13039\/501100003407","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003407","name":"Ministero dell\u2019Istruzione, dell\u2019Universit\u00e0 e della Ricerca","doi-asserted-by":"publisher","award":["CUP B73C22001250006"],"award-info":[{"award-number":["CUP B73C22001250006"]}],"id":[{"id":"10.13039\/501100003407","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100024370","name":"Ministero dell'Istruzione dell'Universit\u00e0 e della Ricerca","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100024370","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","award":["S56329"],"award-info":[{"award-number":["S56329"]}],"id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100016616","name":"Cystic Fibrosis Research Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100016616","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008385","name":"Fondazione per la Ricerca sulla Fibrosi Cistica","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008385","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000897","name":"Cystic Fibrosis Foundation","doi-asserted-by":"publisher","award":["C24M\/21\/041"],"award-info":[{"award-number":["C24M\/21\/041"]}],"id":[{"id":"10.13039\/100000897","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.es","gimopen.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Genetics in Medicine Open"],"published-print":{"date-parts":[[2026]]},"DOI":"10.1016\/j.gimo.2025.103472","type":"journal-article","created":{"date-parts":[[2025,11,20]],"date-time":"2025-11-20T10:49:05Z","timestamp":1763635745000},"page":"103472","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["CFTR rescue in W1282X cystic fibrosis patient-derived intestinal organoids (PDIOs) mediated by translational readthrough-inducing drugs (TRIDs)"],"prefix":"10.1016","volume":"4","author":[{"given":"Riccardo","family":"Perriera","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anabela S.","family":"Ramalho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francois","family":"Vermeulen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emanuele","family":"Vitale","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ivana","family":"Pibiri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea","family":"Pace","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1355-8252","authenticated-orcid":false,"given":"Laura","family":"Lentini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"10","key":"10.1016\/j.gimo.2025.103472_bib1","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1038\/s41580-020-0259-3","article-title":"Human organoids: model systems for human biology and medicine","volume":"21","author":"Kim","year":"2020","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10.1016\/j.gimo.2025.103472_bib2","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1038\/s43586-022-00174-y","article-title":"Organoids","volume":"2","author":"Zhao","year":"2022","journal-title":"Nat Rev Methods Primers"},{"issue":"12","key":"10.1016\/j.gimo.2025.103472_bib3","doi-asserted-by":"crossref","DOI":"10.1002\/ctm2.1499","article-title":"Organoid assessment technologies","volume":"13","author":"Gu","year":"2023","journal-title":"Clin Transl Med"},{"key":"10.1016\/j.gimo.2025.103472_bib4","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2022.854740","article-title":"Human intestinal organoids: promise and challenge","volume":"10","author":"Taelman","year":"2022","journal-title":"Front Cell Dev Biol"},{"key":"10.1016\/j.gimo.2025.103472_bib5","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2023.1268540","article-title":"Organoids as complex (bio)systems","volume":"11","author":"Fernandes","year":"2023","journal-title":"Front Cell Dev Biol"},{"key":"10.1016\/j.gimo.2025.103472_bib6","doi-asserted-by":"crossref","DOI":"10.3389\/fbioe.2023.1058970","article-title":"Primary human organoids models: current progress and key milestones","volume":"11","author":"Cal\u00e0","year":"2023","journal-title":"Front Bioeng Biotechnol"},{"issue":"1","key":"10.1016\/j.gimo.2025.103472_bib7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jcmgh.2021.06.028","article-title":"In vivo studies should take priority when defining mechanisms of intestinal crypt morphogenesis","volume":"13","author":"Guiu","year":"2022","journal-title":"Cell Mol Gastroenterol Hepatol"},{"issue":"1","key":"10.1016\/j.gimo.2025.103472_bib8","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/S2213-2600(19)30337-6","article-title":"The future of cystic fibrosis care: a global perspective","volume":"8","author":"Bell","year":"2020","journal-title":"Lancet Respir Med"},{"issue":"5","key":"10.1016\/j.gimo.2025.103472_bib9","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1111\/apa.15155","article-title":"Cystic fibrosis in the year 2020: a disease with a new face","volume":"109","author":"De Boeck","year":"2020","journal-title":"Acta Paediatr"},{"issue":"6","key":"10.1016\/j.gimo.2025.103472_bib10","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1055\/s-0039-1697591","article-title":"Gastrointestinal and hepatobiliary disease in cystic fibrosis","volume":"40","author":"Gabel","year":"2019","journal-title":"Semin Respir Crit Care Med"},{"issue":"19","key":"10.1016\/j.gimo.2025.103472_bib11","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1056\/NEJMoa1908639","article-title":"Elexacaftor-Tezacaftor-Ivacaftor for cystic fibrosis with a single Phe508del allele","volume":"381","author":"Middleton","year":"2019","journal-title":"N Engl J Med"},{"issue":"12","key":"10.1016\/j.gimo.2025.103472_bib12","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1016\/S2213-2600(24)00249-2","article-title":"Expanding the indication of CFTR modulator combinations for people with cystic fibrosis with non-F508del variants","volume":"12","author":"Burgel","year":"2024","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.gimo.2025.103472_bib13","doi-asserted-by":"crossref","first-page":"121","DOI":"10.3389\/fphar.2019.00121","article-title":"Emerging therapeutic approaches for cystic fibrosis. From gene editing to personalized medicine","volume":"10","author":"Pranke","year":"2019","journal-title":"Front Pharmacol"},{"issue":"1","key":"10.1016\/j.gimo.2025.103472_bib14","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1111\/brv.12657","article-title":"Deciphering the molecular mechanism of stop codon readthrough","volume":"96","author":"Palma","year":"2021","journal-title":"Biol Rev Camb Philos Soc"},{"key":"10.1016\/j.gimo.2025.103472_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/j.pupt.2021.102098","article-title":"Small-molecule drugs for cystic fibrosis: where are we now?","volume":"72","author":"Laselva","year":"2022","journal-title":"Pulm Pharmacol Ther"},{"issue":"7","key":"10.1016\/j.gimo.2025.103472_bib16","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.3390\/ph16071034","article-title":"Amlexanox: readthrough induction and nonsense-mediated mRNA decay inhibition in a Charcot-Marie-Tooth model of hiPSCs-derived neuronal cells harboring a nonsense mutation in GDAP1 gene","volume":"16","author":"Benslimane","year":"2023","journal-title":"Pharmaceuticals (Basel)"},{"issue":"5","key":"10.1016\/j.gimo.2025.103472_bib17","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/j.jcf.2019.02.009","article-title":"Decreased mRNA and protein stability of W1282X limits response to modulator therapy","volume":"18","author":"Aksit","year":"2019","journal-title":"J Cyst Fibros"},{"issue":"8","key":"10.1016\/j.gimo.2025.103472_bib18","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1038\/s41568-022-00481-2","article-title":"Nonsense-mediated RNA decay: an emerging modulator of malignancy","volume":"22","author":"Tan","year":"2022","journal-title":"Nat Rev Cancer"},{"issue":"51","key":"10.1016\/j.gimo.2025.103472_bib19","doi-asserted-by":"crossref","first-page":"E10899","DOI":"10.1073\/pnas.1715501114","article-title":"Aminoglycoside interactions and impacts on the eukaryotic ribosome","volume":"114","author":"Prokhorova","year":"2017","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"8","key":"10.1016\/j.gimo.2025.103472_bib20","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1002\/cpdd.647","article-title":"Safety, tolerability, and pharmacokinetics of single ascending doses of ELX-02, a potential treatment for genetic disorders caused by nonsense mutations, in healthy volunteers","volume":"8","author":"Leubitz","year":"2019","journal-title":"Clin Pharmacol Drug Dev"},{"issue":"1","key":"10.1016\/j.gimo.2025.103472_bib21","doi-asserted-by":"crossref","first-page":"2413","DOI":"10.1038\/s41467-022-30080-6","article-title":"Ataluren binds to multiple protein synthesis apparatus sites and competitively inhibits release factor-dependent termination","volume":"13","author":"Huang","year":"2022","journal-title":"Nat Commun"},{"key":"10.1016\/j.gimo.2025.103472_bib22","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.ejmech.2018.09.057","article-title":"Rescuing the CFTR protein function: introducing 1,3,4-oxadiazoles as translational readthrough inducing drugs","volume":"159","author":"Pibiri","year":"2018","journal-title":"Eur J Med Chem"},{"issue":"17","key":"10.1016\/j.gimo.2025.103472_bib23","doi-asserted-by":"crossref","first-page":"6420","DOI":"10.3390\/ijms21176420","article-title":"Targeting nonsense: optimization of 1,2,4-oxadiazole TRIDs to rescue CFTR expression and functionality in cystic fibrosis cell model systems","volume":"21","author":"Pibiri","year":"2020","journal-title":"Int J Mol Sci"},{"issue":"3","key":"10.1016\/j.gimo.2025.103472_bib24","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.3390\/ijms23031437","article-title":"Assays of CFTR function in vitro, ex vivo and in vivo","volume":"23","author":"Ramalho","year":"2022","journal-title":"Int J Mol Sci"},{"issue":"2","key":"10.1016\/j.gimo.2025.103472_bib25","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00508-2021","article-title":"Forskolin-induced organoid swelling is associated with long-term cystic fibrosis disease progression","volume":"60","author":"Muilwijk","year":"2022","journal-title":"Eur Respir J"},{"issue":"1","key":"10.1016\/j.gimo.2025.103472_bib26","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.02426-2019","article-title":"Correction of CFTR function in intestinal organoids to guide treatment of cystic fibrosis","volume":"57","author":"Ramalho","year":"2021","journal-title":"Eur Respir J"},{"issue":"7","key":"10.1016\/j.gimo.2025.103472_bib27","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1016\/j.celrep.2019.01.068","article-title":"Rectal organoids enable personalized treatment of cystic fibrosis","volume":"26","author":"Berkers","year":"2019","journal-title":"Cell Rep"},{"issue":"1","key":"10.1016\/j.gimo.2025.103472_bib28","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.02379-2018","article-title":"Intestinal organoids to model cystic fibrosis","volume":"54","author":"van Mourik","year":"2019","journal-title":"Eur Respir J"},{"issue":"1","key":"10.1016\/j.gimo.2025.103472_bib29","doi-asserted-by":"crossref","first-page":"93","DOI":"10.3390\/jpm14010093","article-title":"Laboratory tools to predict CFTR modulator therapy effectiveness and to monitor disease severity in cystic fibrosis","volume":"14","author":"Bacalhau","year":"2024","journal-title":"J Pers Med"},{"issue":"3","key":"10.1016\/j.gimo.2025.103472_bib30","first-page":"192","article-title":"Elexacaftor-Tezacaftor-Ivacaftor: the first triple-combination cystic fibrosis transmembrane conductance regulator modulating therapy","volume":"25","author":"Ridley","year":"2020","journal-title":"J Pediatr Pharmacol Ther"},{"issue":"17","key":"10.1016\/j.gimo.2025.103472_bib31","doi-asserted-by":"crossref","first-page":"6420","DOI":"10.3390\/ijms21176420","article-title":"Targeting nonsense: optimization of 1,2,4-oxadiazole TRIDS to rescue CFTR expression and functionality in cystic fibrosis cell model systems","volume":"21","author":"Pibiri","year":"2020","journal-title":"Int J Mol Sci"},{"issue":"1","key":"10.1016\/j.gimo.2025.103472_bib32","article-title":"Protocol for application, standardization and validation of the forskolin-induced swelling assay in cystic fibrosis human colon organoids","volume":"1","author":"Vonk","year":"2020","journal-title":"STAR Protoc"},{"issue":"12","key":"10.1016\/j.gimo.2025.103472_bib33","doi-asserted-by":"crossref","first-page":"4514","DOI":"10.1016\/j.ymthe.2024.10.028","article-title":"Promoting readthrough of nonsense mutations in CF mouse model: biodistribution and efficacy of NV848 in rescuing CFTR protein expression","volume":"32","author":"Fiduccia","year":"2024","journal-title":"Mol Ther"},{"issue":"8","key":"10.1016\/j.gimo.2025.103472_bib34","doi-asserted-by":"crossref","first-page":"3896","DOI":"10.1007\/s00415-023-11687-1","article-title":"Safety and effectiveness of ataluren in patients with nonsense mutation DMD in the STRIDE Registry compared with the CINRG Duchenne Natural History Study (2015-2022): 2022 interim analysis","volume":"270","author":"Mercuri","year":"2023","journal-title":"J Neurol"},{"issue":"9","key":"10.1016\/j.gimo.2025.103472_bib35","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1042\/BCJ20210556","article-title":"No-nonsense: insights into the functional interplay of nonsense-mediated mRNA decay factors","volume":"479","author":"Mailliot","year":"2022","journal-title":"Biochem J"},{"issue":"1","key":"10.1016\/j.gimo.2025.103472_bib36","doi-asserted-by":"crossref","first-page":"344","DOI":"10.3390\/ijms22010344","article-title":"Synergy between readthrough and nonsense mediated decay inhibition in a murine model of cystic fibrosis nonsense mutations","volume":"22","author":"McHugh","year":"2020","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.gimo.2025.103472_bib37","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2022.113886","article-title":"Nonsense codons suppression. An acute toxicity study of three optimized TRIDs in murine model, safety and tolerability evaluation","volume":"156","author":"Corrao","year":"2022","journal-title":"Biomed Pharmacother"},{"issue":"1","key":"10.1016\/j.gimo.2025.103472_bib38","doi-asserted-by":"crossref","first-page":"1966","DOI":"10.1038\/s41467-024-45907-7","article-title":"A spatially-resolved transcriptional atlas of the murine dorsal pons at single-cell resolution","volume":"15","author":"Nardone","year":"2024","journal-title":"Nat Commun"},{"issue":"20","key":"10.1016\/j.gimo.2025.103472_bib39","doi-asserted-by":"crossref","DOI":"10.3390\/ijms242015084","article-title":"Readthrough approach using NV translational readthrough-inducing drugs (TRIDs): a study of the possible off-target effects on natural termination codons (NTCs) on TP53 and housekeeping gene expression","volume":"24","author":"Perriera","year":"2023","journal-title":"Int J Mol Sci"}],"container-title":["Genetics in Medicine Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2949774425015110?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2949774425015110?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T14:17:58Z","timestamp":1773411478000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2949774425015110"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"references-count":39,"alternative-id":["S2949774425015110"],"URL":"https:\/\/doi.org\/10.1016\/j.gimo.2025.103472","relation":{},"ISSN":["2949-7744"],"issn-type":[{"value":"2949-7744","type":"print"}],"subject":[],"published":{"date-parts":[[2026]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"CFTR rescue in W1282X cystic fibrosis patient-derived intestinal organoids (PDIOs) mediated by translational readthrough-inducing drugs (TRIDs)","name":"articletitle","label":"Article Title"},{"value":"Genetics in Medicine Open","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.gimo.2025.103472","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc. on behalf of American College of Medical Genetics and Genomics.","name":"copyright","label":"Copyright"}],"article-number":"103472"}}